CD4 and neoplasm: Further in vivo studies support the immunomodulatory effect of resveratrol analogs on tumor-derived Treg cells, resulting in enhanced anti-tumor immunity through increased tumor-specific cytotoxic T-lymphocyte responses and CD4+ T-cells, supporting the use of resveratrol analogs as adjuvant agents for BC immunotherapy [176].